JP MORGAN/PUT/IDEXX LABORATORIES/460/0.01/19.07.24 Stock

Warrant

DE000JB9J5F3

Market Closed - Bid/Ask 04:05:30 2024-07-11 EDT Pre-market 02:00:24
0.014 EUR -41.67% Intraday chart for JP MORGAN/PUT/IDEXX LABORATORIES/460/0.01/19.07.24 0.033 +135.71%
Current month-30.00%
1 month-53.33%
Date Price Change
24-07-11 0.014 -41.67%
24-07-10 0.024 +41.18%
24-07-09 0.017 0.00%
24-07-08 0.017 -50.00%
24-07-05 0.034 +9.68%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 04:05 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying IDEXX LABORATORIES, INC.
Issuer J.P. Morgan
WKN JB9J5F
ISINDE000JB9J5F3
Date issued 2024-01-05
Strike 460 $
Maturity 2024-07-19 (8 Days)
Parity 100 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.21
Lowest since issue 0.014
Spread 0.03
Spread %75.00%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
487.8 USD
Average target price
564.1 USD
Spread / Average Target
+15.66%
Consensus